Zydus Lifesciences hit 52-week high on share buyback proposal

Shares of Zydus Lifesciences witnessed a surge of over 6 percent in early trade, hitting a 52-week high of Rs 809.20 on February 6. The company announced that its board would consider a proposal for a share buyback on February 9.

If approved, this will mark the second time the pharmaceutical firm has initiated a share buyback. Zydus Lifesciences previously launched a similar plan in June 2022.


By 11:50, the stock was trading 5.26% higher at ₹800.90.

In addition to the buyback proposal, the company is set to announce its quarterly results for the December quarter on the same day as the board meeting.